摘要
目的:观察岩舒注射液联合化疗治疗晚期非小细胞肺癌的疗效。方法:87例非小细胞肺癌的患者,随机分为单纯化疗组43例和化疗中药综合治疗组44例,两组病例的临床资料具有可比性。疗效评价:对照组采用标准NP方案,联合治疗组用以上NP方案+岩舒注射液,每3周为1个治疗周期,3个周期为1疗程。结果:两组患者中,化疗中药综合治疗组在近期疗效、卡氏评分、控制疼痛及毒副反应等方面都优于单纯化疗组,经统计学处理两组之间有显著性差异。结论:NP方案联合中药岩舒注射液治疗非小细胞肺癌具有较好的耐受性和安全性,近期疗效优于单纯化疗组,说明化疗联合中药治疗非小细胞肺癌是一条有效的治疗途径。
OBJECTIVE ： To observe curative effect of late nonsmall - cell lung cancer （NSCLC） treated by chemotherapy combined with yanshu injection. METHODS： 87 cases with NSCLC were randomly divided into simple chemotherapy group （43 cases） and chemotherapy group combined with traditional Chinese medicine （44 cases）. Clinical data of two groups had comparability. Evaluation of curative effect： control group took standard NP project but combined treatment group took NP project plus yanshu injection. Every three weeks constituted one treatment cycle, three cycles constituted one course of treatment. RESULTS： Of two - group patients, group of chemotherapy combined with traditional Chinese medicine surpassed simple chemotherapy group in recent curative effect, karnofsky performance status, pain - control and toxic adverse reactions. There was a great difference between two groups by statistical analysis. CONCLUSION： NP project combined with yanshu injection for the treatment of NSCLC has good tolerance and safety, recent curative effect surpasses that of simple chemotherapy group. It is indicated that chemotherapy combined with traditional Chinese medicine for the treatment of NSCLC is an effective way.
出处
《中国医院用药评价与分析》
2006年第1期43-45,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
岩舒注射液
化疗
晚期非小细胞肺癌
yanshu injection
chemotherapy
late nonsmall- cell lung cancer
